ロード中...
Extracellular Vesicles in Prostate Cancer: New Future Clinical Strategies?
Prostate cancer (PCa) is the most common cancer—excluding skin tumors—in men older than 50 years of age. Over time, the ability to diagnose PCa has improved considerably, mainly due to the introduction of prostate-specific antigen (PSA) in the clinical routine. However, it is important to take into...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3950949/ https://ncbi.nlm.nih.gov/pubmed/24707491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/561571 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|